According to a recent LinkedIn post from Brevel Ltd, the company plans to attend Vitafoods Europe 2026 in Barcelona, positioning itself within a key global forum for nutraceuticals. The post notes that Brevel’s chief business officer, Yfah Burstin, intends to meet with customers and distributors during the event.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The company’s LinkedIn post highlights Purallis™, described there as a pure, consistent Chlorella powder produced via illuminated fermentation and marketed as a clean-label microalgae ingredient rich in vitamin B12, lutein, and zeaxanthin. The emphasis on meetings with formulators, brands, and distributors suggests a focus on business development and potential partnership building.
For investors, the post implies that Brevel is seeking to scale commercial traction for its microalgae-based ingredient portfolio in the nutraceuticals segment. Enhanced visibility at Vitafoods Europe and potential new distribution or formulation relationships could, if realized, support revenue growth and reinforce the company’s positioning in the functional ingredients and alternative protein value chain.